Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Shrinking team NBB
FTE fell two years in a row, from 4 to 3.4.
Financials
Financial year 2025
Cascador Health from Merelbeke-Melle, company number BE0761744166, closed financial year 2025 with a result of € -2.4 million after tax. For that financial year Cascador Health recorded a gross margin of € -1.8 million and equity of € 4.8 million. Compared with financial year 2024, the result moved from € -2.1 million to € -2.4 million. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.
€ 4.8 million
▲ 86% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -2.4 million
▼ 15 % more loss than in 2024
Profit after tax over the fiscal year.
€ 1.7 million
▲ € 1.6 million vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -8.4 million.
People and assets in 2025
3.4
▼ 0.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 408,678
▼ 14% vs 2024
€ 120,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 13,156
▲ € 12,504 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 432,670
€ 44,000 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.
€ 254,878
▼ 21% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 73,678
▲ 20% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -985,537 | € -1,331,770 | € -1,454,414 | € -1,751,906 | ▼ € 297,492 |
| Profit after taxes | € -1,353,187 | € -1,816,353 | € -2,079,323 | € -2,396,808 | ▼ € 317,485 |
| Equity | € 2,722,208 | € 1,184,250 | € 2,595,522 | € 4,838,262 | ▲ 86% |
| Total debts | € 273,437 | € 429,018 | € 467,095 | € 951,492 | ▲ 104% |
| Cash | € 2,590,527 | € 651,734 | € 72,543 | € 1,656,704 | ▲ € 1.6 million |
| Retained profit | € -2,058,775 | € -3,875,128 | € -5,954,451 | € -8,351,259 | ▼ € 2.4 million |
| Bank debt | € 0 | € 0 | € 0 | € 432,670 | |
| Balance sheet total | € 2,995,645 | € 1,613,268 | € 3,168,320 | € 5,813,254 | ▲ 83% |
| Employees (FTE) | 3.7 | 4 | 3.7 | 3.4 | ▼ 0.3 |
Key figures of Cascador Health, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Cascador Health?
What happened at Cascador Health in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Avantix BV stepped down as director. NBB
- Qbic Venture Partners II NV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 2.4 million. Source: NBB ↗
- Noshaq Partners BV became a director. NBB
- CAREVOLUTION BV became a director. NBB
- MALOU CONSULT BV became a director. NBB
- WINGMAN BV stepped down as director. NBB
- Cools Projects BV stepped down as director. NBB
In short
From € 1.4 million loss in 2022 to € 2.4 million loss in 2025.
Paid € 734 in corporate taxes since 2022.
A new publication or filing at Cascador Health? We notify you, reason included.
Follow Cascador HealthDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of QBIC II FUND ARKIV, VOLTA VENTURES II, CAREVOLUTION comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Cascador HealthBehind Cascador Health are Noshaq Partners BV, CAREVOLUTION BV, MALOU CONSULT BV, Alant Health SARL and Luc Dochez. The shares are held by QBIC II FUND ARKIV (17.6%), VOLTA VENTURES II (12.7%) and CAREVOLUTION (11.3%). It owns 100% of Neuroventis and 100% of Fidux Health itself.
Directors
According to the 2025 annual accounts
Director · represented by Marleen Johanna LIMBOURG
Also active at: CAUTION MUTUELLE DES METIERS ET NEGOCES, Fonderies J. Marichal Ketin et Cie, DARDENNE, SOGECOM, VITAVERDE.BIO, HAEMERS Technologies, SPACEBEL, NOSHAQ VENTURE +169 more
since 2026
Director · represented by Joseph Dumortier
Also active at: HOPLR, ICAS BELGIUM, NEUROVENTIS, HELPPER, TRIPTOMATIC
since 2026
since 2026
Alant Health SARL
Director · represented by Hammoud Abed
since 2023
Director · represented by Philip TAILLIEU
Also active at: NEUROVENTIS, Galenus Health, re.alto-energy, ACG Car, Arrive Belgium
since 2022 · until 2028
since 2022 · until 2026
Director · represented by Jan COOLS
Also active at: BELGIAN PARKING REGISTER, Arrive Belgium
since 2022 · until 2026
Director · represented by Steven LEURIDAN
Also active at: EYED PHARMA, Accelleran, Indigo Diabetes, QBIC II FUND ARKIV, Blue Foot Membranes, Aloxy, Sentea, UniD Manufacturing +4 more
since 2022 · until 2028
Shareholders
Participations
100%
100%
Establishments
Establishment units
Physical locations of this company
Kardinaal Mercierlaan 1A
9090 Merelbeke-Melle
Molenstraat 24a
9140 Temse
Active since 18 January 2021
Vrijwilligerslaan 19
1160 Oudergem
Active since 30 January 2026
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 9 companies are registered at this address.
All companies at this address →COOLS PROJECTS same network
€ 667,521 gross margin · 2025
THV MOBILE CITY
Be-Mobile Group
€ -409,332 gross margin · 2025
BELGIAN PARKING REGISTER same network
€ 415,853 gross margin · 2025
Fidux Health same network
€ 178,946 gross margin · 2025
+4 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0761.744.166
- VAT number
- BE 0761.744.166
- Registered office
- Kardinaal Mercierlaan 1A, 9090 Merelbeke-Melle
- Names & denominations
- Cascador Health
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 January 2021
- Peppol
- Active · Active since 13 Mar 2026
- Activities · NACE
Ontwerpen van computerprogramma’s
Ontwerpen en programmeren van computerprogramma's
Overige diensten op het gebied van informatietechnologie en computer